Infectious Diseases Related Content

A new study led by Children's National Hospital researchers shows that minority and socioeconomically disadvantaged children have significantly higher rates of COVID-19 infection.

Paul De Raeve, Secretary General and Elisabeth Adams, President of the European Federation of Nurses Associations state the case for being better prepared for the next health crisis in the European Union in light of COVID-19.

Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.

EIB and CureVac have signed a €75m loan agreement to develop a large-scale production of vaccines, including CureVac's vaccine candidate against SARS-CoV-2.

Gerald Misinzo and Mark Rweyemamu from SACIDS Foundation for One Health provide a detailed look at one health research by the Africa centres of excellence for infectious diseases of humans and animals.

Here, experts Stephan Pleschka, Oliver Planz and Stephan Ludwig walk us through the constant threat of influenza virus outbreaks and the benefit of enduring research in antiviral drug development.

Professor Behzad Samii, professor of operations and supply chain management at Vlerick Business School, discusses how to fairly circulate a COVID-19 vaccine.

Jane Kinghorn, Director at UCL Translational Research Office and Nick McNally, Managing Director Research UCL/UCLH, describe some of the approaches taken by the scientific community in supporting hospitals dealing with the COVID-19 pandemic.

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group sheds light on the spread and expansion of several types of the influenza virus in Africa.

Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.

The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.

A group of experts from the World Health Organization explain the Global Influenza Strategy for 2019-2030 that charts the path towards greater global influenza prevention, control, and preparedness through 2030.

Here, Alberto Mantovani of the Endocrine Disruptors Project here discusses what there is to learn from the recent COVID-19 pandemic.

Scientists at TCS designed novel chemical compounds using AI that can inhibit the 3CL protease of SARS-CoV-2, which is responsible for viral replication. Ananth Krishnan, Chief Technology Office, TCS, discusses the research here.

Steve Sawyer, managing director of Access Health & Social Care, explains how technology is helping care providers to protect the safety of frontline care workers during the COVID-19 pandemic.

Here, a group of seasoned experts discusses the important role of prevention and reduction of mental stress in the general population and in sensitive groups in the context of the COVID-19 pandemic.

Countries like Hong Kong and South Korea have been tracing their potential infection sources since January: How will the UK implement an Asian COVID strategy?

The University of Barcelona explain to the world how to build a ventilator inexpensively, which functions like a high-quality commercial device.

Discussing infections in light of the recent pandemic of COVID-19, Alberto Mantovani of Endocrine Disruptors Project delves in to what we can learn.

In this North America April 2020 edition, David Goff at the National Heart, Lung, and Blood Institute, details the support for heart and vascular health research.